1. Home
  2. GH vs FCNCA Comparison

GH vs FCNCA Comparison

Compare GH & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$176.79

Market Cap

22.9B

Sector

Health Care

ML Signal

HOLD

Logo First Citizens BancShares Inc.

FCNCA

First Citizens BancShares Inc.

HOLD

Current Price

$2,053.98

Market Cap

23.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
FCNCA
Founded
2011
1898
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
23.2B
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
GH
FCNCA
Price
$176.79
$2,053.98
Analyst Decision
Strong Buy
Buy
Analyst Count
19
11
Target Price
$119.79
★ $2,199.64
AVG Volume (30 Days)
★ 1.7M
58.4K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
★ 0.43%
EPS Growth
★ 6.74
N/A
EPS
N/A
★ 97.95
Revenue
$982,021,000.00
★ $9,541,000,000.00
Revenue This Year
$33.30
$3.43
Revenue Next Year
$28.27
N/A
P/E Ratio
★ N/A
$21.42
Revenue Growth
★ 32.88
N/A
52 Week Low
$60.46
$1,625.08
52 Week High
$183.51
$2,296.30

Technical Indicators

Market Signals
Indicator
GH
FCNCA
Relative Strength Index (RSI) 57.52 39.48
Support Level $153.88 $2,028.09
Resistance Level $183.51 $2,135.18
Average True Range (ATR) 7.66 53.36
MACD 0.22 -6.13
Stochastic Oscillator 73.14 14.15

Price Performance

Historical Comparison
GH
FCNCA

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About FCNCA First Citizens BancShares Inc.

First Citizens is a US regional bank with total assets of around $237 billion as of June 30, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. In 2025, First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing.

Share on Social Networks: